PARP1 and nasopharyngeal carcinoma: 5-azacyclobutane can enhance the expression of caspase-3 and the cleavage of PARP induced by ionizing radiation, thereby increasing the radiosensitivity of C666-1 nasopharyngeal carcinoma cells (Cai et al., 2017).